Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Zoetis Inc. (ZTS)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
174.45-1.22 (-0.69%)
At close: 04:03PM EDT
173.90 -0.55 (-0.32%)
After hours: 06:26PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close175.67
Open175.17
Bid171.74 x 1000
Ask178.28 x 1000
Day's Range173.24 - 176.17
52 Week Range154.18 - 249.27
Volume1,243,616
Avg. Volume1,810,714
Market Cap81.667B
Beta (5Y Monthly)0.72
PE Ratio (TTM)39.56
EPS (TTM)4.41
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & Yield1.30 (0.74%)
Ex-Dividend DateJul 20, 2022
1y Target Est228.73
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-12% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ZTS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Zoetis Inc.
    Analyst Report: Zoetis Inc.Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
    Rating
    Fair Value
    Economic Moat
    11 days agoMorningstar
View more
Advertisement
Advertisement